Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Aclaris Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 136
- +17 vs. Q4 2025
- Shares held
- 109.2M
- +33.7M (+44.6%) vs. Q4 2025
- Total value
- $409.4M
- +$182.1M (+80.1%) vs. Q4 2025
- New holders
- 33
- 41 more added
- Sold out
- 16
- 40 more reduced
3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 148 | $630.0M |
| Q1 2026 | 136 | $409.4M |
| Q4 2025 | 122 | $252.1M |
| Q3 2025 | 103 | $162.8M |
| Q2 2025 | 96 | $130.4M |
| Q1 2025 | 109 | $143.8M |
| Q4 2024 | 98 | $217.0M |
| Q3 2024 | 81 | $58.5M |
| Q2 2024 | 98 | $58.1M |
| Q1 2024 | 98 | $67.5M |
| Q4 2023 | 107 | $61.4M |
| Q3 2023 | 138 | $480.0M |
| Q2 2023 | 133 | $737.2M |
| Q1 2023 | 149 | $579.3M |
| Q4 2022 | 128 | $1.04B |
| Q3 2022 | 127 | $1.00B |
| Q2 2022 | 115 | $883.3M |
| Q1 2022 | 110 | $1.02B |
| Q4 2021 | 133 | $814.9M |
| Q3 2021 | 126 | $1.02B |
| Q2 2021 | 128 | $983.4M |
| Q1 2021 | 97 | $1.14B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Logos Global Management LP | 500,000 | $1.88M | 0.10% | −100,000−16.7% | Reduced |
| Monashee Investment Management LLC | 500,000 | $1.88M | 1.02% | +500,000 | New |
| Panagora Asset Management Inc | 502,290 | $1.88M | 0.01% | +434,100+636.6% | Added |
| Renaissance Technologies LLC | 502,631 | $1.88M | 0.00% | −622,700−55.3% | Reduced |
| Dimensional Fund Advisors LP | 511,461 | $1.91M | 0.00% | +240,611+88.8% | Added |
| Goldman Sachs Group Inc | 588,691 | $2.21M | 0.00% | −43,811−6.9% | Reduced |
| Vanguard Fiduciary Trust Co | 628,859 | $2.36M | 0.00% | +628,859 | New |
| Marshall Wace, LLP | 712,984 | $2.67M | 0.00% | +227,483+46.9% | Added |
| Three Bridge Wealth Advisors, LLC | 714,823 | $2.68M | 0.74% | 00.0% | Unchanged |
| Northern Trust Corp | 728,225 | $2.73M | 0.00% | +63,967+9.6% | Added |
| Millennium Management LLC | 756,127 | $2.84M | 0.00% | −297,119−28.2% | Reduced |
| D. E. Shaw & Co., Inc. | 900,804 | $3.38M | 0.00% | −1,195,847−57.0% | Reduced |
| Aldebaran Capital, LLC | 947,162 | $3.55M | 2.72% | −7,100−0.7% | Reduced |
| Deutsche Bank AG | 997,850 | $3.74M | 0.00% | +10,499+1.1% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 1,418,360 | $5.32M | 0.01% | −15,804−1.1% | Reduced |
| Woodline Partners LP | 1,485,623 | $5.57M | 0.02% | +743,614+100.2% | Added |
| Acadian Asset Management LLC | 1,539,791 | $5.77M | 0.01% | −582,608−27.5% | Reduced |
| Palo Alto Investors LP | 1,613,430 | $6.05M | 0.93% | +46,590+3.0% | Added |
| Vanguard Portfolio Management LLC | 1,656,066 | $6.21M | 0.00% | +1,656,066 | New |
| Braidwell LP | 1,699,116 | $6.37M | 0.21% | +1,699,116 | New |
| Kalehua Capital Management LLC | 1,832,365 | $6.87M | 4.86% | +1,832,365 | New |
| State Street Corp | 2,008,746 | $7.53M | 0.00% | +502,343+33.3% | Added |
| Citadel Advisors LLC | 2,249,319 | $8.43M | 0.01% | +1,044,038+86.6% | Added |
| Geode Capital Management, LLC | 2,423,691 | $9.09M | 0.00% | +30,919+1.3% | Added |
| Morgan Stanley | 2,746,302 | $10.3M | 0.00% | −669,088−19.6% | Reduced |
| Balyasny Asset Management LLC | 3,361,328 | $12.6M | 0.02% | +3,361,328 | New |
| Adage Capital Partners GP, L.L.C. | 3,871,000 | $14.5M | 0.02% | +500,000+14.8% | Added |
| Decheng Capital LLC | 4,041,736 | $15.2M | 2.29% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 4,472,650 | $16.8M | 0.99% | +18,909+0.4% | Added |
| Frazier Life Sciences Management, L.P. | 4,925,374 | $18.5M | 0.48% | +4,925,374 | New |
| Vanguard Capital Management LLC | 5,167,469 | $19.4M | 0.00% | +5,167,469 | New |
| Vivo Capital, LLC | 6,666,666 | $25.0M | 2.08% | −2,222,222−25.0% | Reduced |
| Ra Capital Management, L.P. | 6,804,072 | $25.5M | 0.27% | +6,804,072 | New |
| BlackRock, Inc. | 7,407,065 | $27.8M | 0.00% | +602,224+8.8% | Added |
| Deep Track Capital, LP | 9,345,000 | $35.0M | 0.72% | +9,345,000 | New |
| BML Capital Management, LLC | 14,250,000 | $53.4M | 34.38% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −318,426−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −255,400−100.0% | Sold out |
| Seven Fleet Capital Management LP | 0 | $0 | 0.00% | −107,419−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −87,175−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −42,435−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −27,540−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −27,216−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −24,186−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −22,259−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −16,670−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −12,433−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −12,408−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −2,883−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −730−100.0% | Sold out |
| Quattro Advisors LLC | 0 | $0 | 0.00% | −372−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Kotler Kevin | – | – | – | – | Not filed |
| Motiv8 Investments LLC | – | – | – | – | Not filed |